Vestipitant

DB11949InvestigationalSmall molecule

Vestipitant has been investigated for the treatment of Tinnitus.

Mechanism: Pharmacologically active on Substance-P receptor
Curator reviewed
Formula / weight: C₂₃H₂₄F₇N₃O · 491.454 g/mol (avg)
Code names: GW-597599

Resolves to

Compound

Structure

InChIKeySBBYBXSFWOLDDG-JLTOFOAXSA-NSMILESC[C@@H](N(C)C(=O)N1CCNC[C@@H]1C1=CC=C(F)C=C1C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F

Targets

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vestipitant, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.